Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

27 Feb 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for BOUL.ST


Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that... (more)
No analyst recommendations are available for BOUL.ST.


Beta: 0.74
Market Cap(Mil.): kr336.56
Shares Outstanding(Mil.): 4.71
Dividend: 0.60
Yield (%): 0.84


  BOUL.ST Industry Sector
P/E (TTM): 11.10 35.56 40.21
EPS (TTM): 6.44 -- --
ROI: 18.75 7.13 16.34
ROE: 20.37 11.30 17.27
Search Stocks

BRIEF-Boule Diagnostics Q4 operating profit up to SEK 7.1 million

* Q4 net sales 90.1 million Swedish crowns ($10.70 million) versus 72.2 million crowns year ago

13 Feb 2015

BRIEF-Boule Diagnostics wins strategic deal

* Has won the procurement of instruments for blood cell counting in primary care in Östergötland

08 Jan 2015

BRIEF-Boule Diagnostics introduces new automatic blood cell counters

* Says the instruments will gradually replace the existing products under the brands Medonic and Swelab

17 Nov 2014

BRIEF-Boule Diagnostics Q3 operating profit up to SEK 10.0 million

* Q3 operating profit 10.0 million Swedish crowns versus loss 91.7 million crowns

05 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks